aldehyd
inhibitor
zalaalaphecho
synthes
shown
cnmr
react
activ
site
serin
hydroxyl
group
alphachymotrypsin
form
two
diastereomer
hemiacet
hemiacet
oxyanion
format
occur
pk
valu
show
chymotrypsin
reduc
oxyanion
pk
valu
pk
unit
stabil
oxyanion
diastereoisom
kj
mol
ph
small
effect
bind
conclud
oxyanion
format
signific
effect
bind
aldehyd
inhibitor
compar
bind
zalaalaphecho
zalaalapheh
estim
aldehyd
group
increas
fold
ph
effect
molar
activ
site
serin
hydroxi
group
less
effect
correspond
glyoxal
inhibitor
use
hnmr
shown
histidin
pk
free
chymotrypsin
rais
zalaalaphecho
bound
conclud
oxyanion
format
minor
role
rais
histidin
pk
aldehyd
hydrogen
must
replac
larger
group
rais
histidin
pk
n
give
stereospecif
format
tetrahedr
intermedi
result
show
larg
increas
pk
activ
site
histidin
need
activ
site
serin
hydroxyl
group
effect
molar
specif
peptid
aldehyd
inhibitor
usual
form
replac
carboxi
termin
carboxyl
group
aldehyd
group
substrat
deriv
aldehyd
inhibitor
often
highli
specif
potent
inhibitor
serin
proteas
consequ
use
target
specif
serin
proteas
prostat
specif
antigen
proteasom
sar
proteas
hope
use
help
treatment
condit
prostat
cancer
sever
acut
respiratori
syndrom
recent
develop
approach
enabl
us
quantifi
much
peptid
warhead
contribut
inhibitor
potenc
use
determin
glyoxyl
group
carboxyl
group
contribut
inhibitor
potenc
serin
proteas
chymotrypsin
paper
use
approach
determin
aldehyd
group
contribut
inhibitor
potenc
chymotrypsin
ratelimit
step
peptid
catalysi
serin
proteas
thought
either
format
breakdown
tetrahedr
intermedi
form
addit
hydroxyl
group
catalyt
serin
carbonyl
carbon
peptid
bond
hydrolys
tight
bind
aldehyd
cystein
proteas
papain
attribut
format
thiohemiacet
addit
thiolat
ion
catalyt
cystein
carbonyl
peptid
bond
hydrolys
analog
tetrahedr
intermedi
form
catalysi
similar
propos
made
aldehyd
found
potent
inhibitor
serin
proteas
elastas
use
hnmr
indirect
evid
hemiacet
format
serin
proteas
chymotrypsin
obtain
use
satur
transfer
direct
observ
hemiacet
signal
report
use
fnmr
nacetylpfluorophenylalin
cnmr
studi
aldehyd
inhibitor
acetylphecho
bind
shown
two
hemiacet
form
cnmr
shown
aldehyd
inhibitor
leupeptin
nacetylleuleuleuargcho
also
form
two
diastereomer
hemiacet
trypsin
howev
acetylleuphecho
report
one
hemiacet
signal
observ
fact
small
chang
fold
k
valu
observ
ph
aldehyd
inhibitor
bind
chymotrypsin
led
suggest
hemiacet
form
chymotrypsin
remain
neutral
ph
likewis
fact
chemic
shift
hemiacet
observ
acetylphecho
acetylleuphecho
titrat
significantli
ph
n
use
support
suggest
hemiacet
neutral
ph
howev
trypsin
hydroxi
group
diastereomer
hemiacet
form
leupeptin
acetylleuphecho
ioniz
show
oxyanion
format
pka
valu
also
shown
oxyanion
format
chymotrypsin
glyoxal
inhibitor
complex
form
zalaalaphecocho
scheme
therefor
studi
use
cnmr
determin
whether
oxyanion
format
correspond
chymotrypsinaldehyd
inhibitor
complex
form
zalaalaphecho
scheme
ph
allow
us
compar
chymotrypsin
stabil
oxyanion
format
hemiacet
hemiket
recent
develop
procedur
allow
us
quantifi
hemiket
format
chymotrypsinglyox
inhibitor
complex
determin
effect
molar
hydroxyl
group
catalyt
serin
residu
complex
studi
use
similar
approach
quantifi
hemiacet
format
chymotrypsinaldehyd
inhibitor
complex
determin
effect
molar
hydroxyl
group
catalyt
serin
residu
complex
also
undertak
extens
hnmr
studi
ioniz
state
activ
site
histidin
residu
chang
aldehyd
inhibitor
bound
allow
us
determin
oxyanion
format
affect
histidin
pk
also
whether
high
histidin
pk
requir
activ
site
serin
hydroxyl
group
high
effect
molar
final
discuss
mechanist
signific
result
zalaalapheh
scheme
synthes
describ
petrillo
et
al
cooch
cocho
scheme
synthes
describ
cosgrov
et
al
cooch
mg
mmol
equiv
suspend
anhydr
tetrahydrofuran
ml
ad
stir
suspens
lialh
mg
mmol
equiv
anhydr
thf
ml
nitrogen
reaction
mixtur
left
stir
h
follow
min
room
temperatur
reaction
mixtur
cool
ethyl
acet
ml
cautious
ad
dropwis
mixtur
follow
dropwis
addit
ice
cold
water
ml
result
mixtur
stir
min
layer
partit
aqueou
layer
extract
ethyl
acet
ml
combin
organ
layer
wash
brine
ml
dri
mgso
filter
solvent
remov
vacuo
give
crude
product
purif
silica
chromatographi
use
ch
cl
meoh
eluant
gave
product
white
solid
mp
yield
g
mmol
cnmr
analysi
gave
follow
data
c
mhz
dmso
sonic
suspens
ch
oh
mg
mmol
equiv
anhydr
ch
cl
ml
ad
stir
solut
pyridinium
chlorochrom
mg
mmol
equiv
celit
mg
anhydr
ch
cl
ml
reaction
mixtur
left
stir
h
time
silica
ca
g
ad
solvent
remov
vacuo
residu
purifi
silica
chromatographi
use
ethylacet
eluant
gave
product
white
solid
yield
g
mmol
cnmr
analysi
gave
follow
data
c
mhz
crystal
lyophil
obtain
sigma
chemic
co
amount
fulli
activ
enzym
determin
describ
finucan
et
al
k
valu
inhibit
chymotrypsincatalyz
hydrolysi
succinylalaalaprophepna
ph
potassium
phosphat
buffer
determin
determin
k
ob
valu
differ
inhibitor
concentr
plot
k
ob
versu
inhibitor
concentr
k
determin
intercept
xaxi
k
valu
determin
k
describ
nmr
spectra
record
bruker
avanc
drx
standardbor
spectromet
oper
mhz
cnuclei
mmdiamet
nmr
tube
ml
sampl
use
cnmr
spectroscopi
cnmr
spectral
condit
sampl
time
domain
data
point
spectral
width
ppm
acquisit
time
relax
delay
time
puls
angl
transient
record
per
spectrum
composit
puls
h
decoupl
w
use
reduc
w
relax
delay
minim
dielectr
heat
maintain
nuclear
overhaus
effect
hnmr
spectra
record
mhz
use
nmr
tube
spectral
condit
use
observ
hbond
proton
ppm
time
domain
data
point
spectral
width
ppm
acquisit
time
relax
delay
angl
dummi
scan
transient
record
per
spectrum
water
suppress
carri
waterg
puls
sequenc
puls
sequenc
spectra
transform
use
exponenti
weight
factor
hz
h
c
chemic
shift
quot
rel
tetramethylsilan
ppm
chemic
shift
dimethyl
sulfoxid
ppm
use
secondari
refer
cnmr
spectra
obtain
aqueou
solut
aqueou
sampl
contain
vv
h
obtain
deuterium
lock
signal
aqueou
solvent
ph
contain
mm
sodium
phosphat
buffer
dmso
h
cho
scheme
gave
signal
ppm
j
ch
valu
hz
hz
respect
spin
lattic
relax
time
determin
invers
recoveri
method
signal
ppm
spin
lattic
relax
time
use
quantit
cnmr
determin
hydrat
constant
k
mean
determin
ad
cho
fig
fig
new
signal
observ
ppm
j
ch
hz
ppm
j
ch
hz
ph
fig
signal
ppm
due
dmso
vv
use
make
inhibitor
stock
solut
signal
ppm
j
ch
hz
fig
due
small
excess
inhibitor
fig
signal
valu
respect
assign
diastereomer
hemiacet
form
activ
site
serin
hydroxyl
group
react
cenrich
inhibitor
aldehyd
group
hydrat
form
diastereoisom
would
give
one
nmr
signal
therefor
fact
observ
two
cnmr
signal
confirm
two
diastereomer
hemiacet
form
inhibitor
bound
hydrat
inhibitor
tightli
bound
acid
alkalin
ph
tabl
calcul
enzym
satur
inhibitor
ph
hemiacet
like
hemiket
expect
chemic
shift
ppm
larger
hydrat
therefor
signal
ppm
chemic
shift
close
expect
hydroxyl
group
activ
site
serin
chymotrypsin
form
hemiacet
inhibitor
aldehyd
group
process
stereospecif
one
hemiacet
signal
observ
howev
two
hemiacet
signal
observ
conclud
hemiacet
format
stereospecif
area
signal
ppm
ppm
fig
proport
correspond
hemiacet
ph
respect
similar
proport
obtain
ph
fig
due
line
broaden
accur
measur
could
made
intermedi
ph
howev
similar
proport
also
obtain
ph
fig
ph
fig
mean
valu
diastereoisom
signal
ppm
diastereoisom
signal
ppm
use
cnmr
two
diastereomer
thiohemiacet
first
observ
cystein
proteas
papain
incub
aldehyd
inhibitor
subsequ
two
hemiacet
observ
cnmr
aldehyd
inhibitor
react
serin
proteas
chymotrypsin
trypsin
hemiacet
form
leupeptin
nacetylleuleuargcho
react
trypsin
similar
chemic
shift
proport
except
signal
higher
chemic
shift
predomin
wherea
present
work
signal
lower
chemic
shift
predomin
k
valu
inhibit
chymotrypsin
catalyz
hydrolysi
succinylalaalaprophepna
aldehyd
inhibitor
zalaalaphecho
ph
determin
depend
observ
k
valu
succinylalaalaprophepna
concentr
inhibitor
present
k
valu
zaafh
zaafcho
estim
aldehyd
group
increas
fold
tabl
glyoxal
group
zaafcocho
bound
time
tightli
aldehyd
group
zaafcho
tabl
cnmr
shown
zaafcho
react
chymotrypsin
form
two
hemiacet
one
smaller
signal
chemic
shift
ppm
larger
signal
chemic
shift
ppm
ph
fig
assum
k
ob
zaafh
scheme
good
approxim
disassoci
constant
k
correspond
chymotrypsinzaafcho
complex
ea
ald
scheme
k
ha
ob
eq
calcul
k
ha
ob
hemiacet
format
zaafcho
similar
magnitud
k
hk
ob
hemiket
format
zaafcocho
tabl
use
eq
valu
k
hk
ob
mean
proport
diastereoisom
ppm
ppm
respect
k
k
determin
two
diastereoisom
tabl
hemiacet
format
chymotrypsinaldehyd
inhibitor
complex
first
order
process
k
haob
hemiacet
ea
wherea
hydrat
free
aldehyd
inhibitor
water
second
order
process
k
hemiacet
aldehyd
h
k
calcul
divid
k
ob
k
ob
hemiacet
aldehyd
molar
water
ratio
k
haob
k
therefor
effect
molar
serin
hydroxyl
group
hemiacet
format
effect
molar
molar
water
requir
effect
catalyt
serin
hydroxyl
group
form
hemiacet
inhibitor
aldehyd
group
effect
molar
activ
site
serin
hydroxyl
group
time
lower
hemiacet
format
zaafcho
scheme
compar
hemiket
format
keto
carbon
glyoxal
group
zaafcocho
scheme
effect
ph
cnmr
signal
zalaalaphecho
presenc
absenc
increas
ph
chemic
shift
larg
signal
small
signal
ppm
increas
fig
chemic
shift
larg
signal
fig
increas
ppm
ppm
pk
fig
also
small
increas
chemic
shift
ppm
pk
scheme
minim
scheme
hemiacet
format
chymotrypsin
tabl
effect
molar
catalyt
serin
form
hemiket
glyoxal
inhibitor
hemiacet
aldehyd
inhibitor
ph
fig
total
titrat
shift
ppm
similar
ppm
observ
format
hemiket
oxyanion
correspond
hemiket
form
glyoxal
inhibitor
zalaalaph
cocho
react
chymotrypsin
tabl
therefor
titrat
shift
assign
format
hemiacet
oxyanion
zalaalaphecho
form
hemiacet
chymotrypsin
ioniz
ion
pair
caus
conform
chang
inactiv
chymotrypsin
bind
ligand
chemic
modif
activ
site
serin
hydroxyl
known
rais
pka
ion
pair
valu
assign
pka
ioniz
ion
pair
smaller
signal
ppm
fig
titrat
similar
pka
fig
titrat
shift
smaller
tabl
pk
valu
hemiacet
oxyanion
inhibitor
complex
much
smaller
oxyanion
pk
inhibitor
hydrat
fig
show
chymotrypsin
stabil
hemiacet
oxyanion
diastereoisom
similar
amount
order
quantifi
stabil
need
determin
hemiacet
pk
absenc
enzym
stabil
done
use
free
energi
relationship
pk
cooh
scheme
determin
cnmr
use
relationship
zaafcooh
substitu
constant
substitu
zaaf
substitu
constant
eo
use
valu
relationship
pk
estim
pk
oxyanion
hemiacet
form
chymotrypsin
zalaalaphecho
react
therefor
chymotrypsin
lower
pk
larger
fig
pk
unit
pk
smaller
fig
similar
amount
tabl
oxyanion
hemiacet
therefor
stabil
kj
mol
tabl
glyoxal
inhibitor
zaafcocho
fold
decreas
bind
ph
decreas
fold
decreas
bind
increas
ph
tabl
howev
aldehyd
inhibitor
zaafcho
much
smaller
decreas
bind
ph
decreas
tabl
howev
ph
fold
decreas
bind
aldehyd
glyoxal
tabl
similar
small
fold
increas
k
ph
bzphecho
chymotrypsin
led
suggest
hemiacet
neutral
throughout
ph
rang
result
show
oxyanion
format
occur
accord
pka
conclud
suggest
incorrect
hemiacet
neutral
ph
higher
zaafcocho
hemiket
format
k
hkob
unchang
ph
tabl
howev
result
better
bind
aldehyd
compar
glyoxal
ph
fold
increas
hemiacet
format
k
haob
ph
zaafcho
tabl
contrast
zapfcocho
hemiket
format
decreas
ph
bind
zaafh
decreas
fold
ph
aldehyd
glyoxal
bind
fold
ph
hydrat
signal
fit
paramet
pka
ppm
ppm
hemiacet
signal
c
fit
paramet
pk
ppm
ppm
hemiacet
signal
b
continu
line
calcul
use
equat
ob
h
k
h
k
k
k
h
k
h
k
k
fit
paramet
pk
pk
ppm
ppm
ppm
tabl
titrat
constant
ph
depend
chang
chemic
shift
cenrich
carbon
zalaalaph
cho
zalaalaph
tabl
similar
decreas
observ
zapfh
zapfcocho
support
suggest
increas
due
conform
chang
result
ioniz
ion
pair
chymotrypsin
chymotrypsin
signal
ppm
assign
proton
posit
charg
imidazolium
ring
signal
ppm
assign
proton
neutral
imidazol
ring
glyoxal
complex
zalaalaphecocho
signal
ppm
ppm
present
low
high
ph
demonstr
bind
glyoxal
inhibitor
rais
pka
activ
site
histidin
valu
n
contrast
aldehyd
complex
zalaalaphecho
signal
bare
discern
fig
similar
observ
free
condit
fig
howev
signal
ppm
ppm
clearli
visibl
low
ph
presenc
fig
absenc
fig
zalaalaphecho
unlik
analog
glyoxal
inhibitor
signal
disappear
increas
ph
replac
singl
larg
signal
ppm
ph
n
fig
signal
fig
similar
observ
free
fig
signal
bare
visibl
fig
show
exchang
broaden
aldehyd
inhibitor
compar
glyoxal
analogu
therefor
exchang
rate
faster
aldehyd
inhibitor
glyoxal
inhibitor
also
show
aldehyd
inhibitor
histidin
pka
must
rang
spectra
glyoxal
inhibitor
spectra
obtain
use
waterg
puls
sequenc
water
suppress
puls
sequenc
effect
smaller
chemic
shift
rang
ppm
effect
detect
exchang
broaden
signal
therefor
use
puls
sequenc
follow
ioniz
imidazolium
ion
ph
titrat
proton
ppm
presenc
absenc
zalaalaphecho
fig
ph
depend
chemic
shift
hbond
proton
fig
pk
valu
free
chymotrypsin
zalaalaphechochymotrypsin
complex
fig
fig
respect
similar
valu
obtain
free
chymotrypsin
fig
zalaalaphechochymotrypsin
complex
fig
respect
histidin
pk
valu
free
enzym
similar
valu
report
respect
increas
histidin
pk
ad
zalaalaphecho
contrast
observ
decreas
histidin
pka
acetylleuphecho
bind
aldehyd
wide
use
potent
inhibitor
serin
proteas
result
show
aldehyd
group
increas
inhibitor
potenc
factor
tabl
potenc
inhibit
usual
attribut
abil
aldehyd
group
react
activ
site
serin
hydroxyl
group
form
hemiacet
mimic
tetrahedr
intermedi
form
substrat
catalysi
fact
aldehyd
group
zaafcho
readili
hydrat
k
illustr
readili
hydroxyl
group
react
aldehyd
carbonyl
carbon
give
tetrahedr
speci
howev
solvent
water
hydroxyl
group
compet
enzym
catalyt
serin
hydroxyl
decreas
concentr
nonhydr
aldehyd
group
react
hydroxyl
group
catalyt
serin
residu
therefor
observ
k
valu
normal
correct
allow
use
k
iob
k
k
hyd
case
k
valu
zaafcho
would
decreas
factor
zaafcocho
shown
activ
site
serin
hydroxyl
group
chymotrypsin
react
keto
carbonyl
glyoxal
group
lower
k
therefor
observ
k
reduc
factor
similar
correct
k
valu
obtain
aldehyd
inhibitor
therefor
fact
glyoxal
inhibitor
fold
tightli
correspond
aldehyd
inhibitor
due
fact
glyoxal
inhibitor
hemiket
format
occur
less
effect
hydrat
keto
carbon
oppos
heavili
hydrat
aldehyd
carbon
inhibit
chymotrypsin
glyoxal
inhibitor
shown
stereospecif
one
diastereomer
hemiket
form
howev
correspond
peptid
aldehyd
inhibitor
inhibit
fulli
stereospecif
two
diastereoisom
form
diastereoisom
ppm
predomin
diastereoisom
ppm
make
hemiacet
form
two
diastereoisom
also
observ
nacetylphecho
incub
chymotrypsin
proport
chemic
shift
report
likewis
leupeptin
incub
trypsin
two
similar
diastereoisom
detect
chemic
shift
ppm
ppm
titrat
pk
valu
present
work
chymotrypsin
diastereoisom
form
zalaalaphecho
titrat
tabl
hemiacet
hemiket
oxyanion
stabil
aldehyd
zaafcho
glyoxal
zaafcocho
inhibitor
complex
form
inhibitor
complex
chymotrypsin
oxyanion
pk
pk
decreas
oxyanion
stabil
pk
aw
water
pk
ae
enzym
pk
aw
pk
ae
kj
mol
cho
b
cho
c
hemiket
zaaf
cocho
e
pk
hemiacet
water
calcul
describ
text
b
pk
form
scheme
c
pk
form
scheme
pk
hemiket
water
calcul
describ
hemiacet
except
substitu
constant
use
aldehyd
group
glyoxal
inhibitor
e
pk
hemiket
form
chymotrypsin
pk
valu
similar
tabl
suggest
similar
environ
xray
crystallograph
studi
aldehyd
inhibitor
bind
serin
proteas
shown
hemiacet
format
stereospecif
aldehyd
inhibitor
two
diastereomer
hemiacet
form
one
oxyanion
oxyanion
hole
diastereoisom
oxyanion
point
toward
activ
site
histidin
hydrogen
bond
oxyanion
oxyanion
hole
backbon
amid
nitrogen
howev
diastereoisom
oxyanion
nitrogen
posit
charg
imidazolium
ion
therefor
oxyanion
differ
electrostat
environ
two
diastereoisom
would
expect
would
significantli
differ
pk
valu
observ
two
diastereoisomer
hemiacet
observ
acetylleuphechotrypsin
complex
fact
zalaalaphechochymotrypsin
complex
oxyanion
pk
valu
diastereoisom
suggest
oxyanion
diastereoisom
similar
electrostat
environ
sinc
bind
zalaalaphecho
rais
pk
fig
oxyanion
pk
valu
diastereomer
hemiacet
fig
expect
posit
charg
histidin
residu
play
import
role
lower
oxyanion
pk
bind
acetylleuphecho
result
format
hemiacet
signal
ppm
titrat
ph
chemic
shift
valu
ppm
larger
observ
ppm
oxyanion
zalaalaphecho
fulli
form
fig
c
suggest
oxyanion
fulli
form
ph
acetylleuphecho
pk
b
histidin
pk
acetylleuphecho
complex
show
abl
stabil
oxyanion
howev
glyoxal
inhibitor
histidin
pka
rais
n
therefor
clear
aldehyd
inhibitor
like
glyoxal
inhibitor
bound
tightli
chymotrypsin
much
less
effect
rais
pka
activ
site
histidin
chymotrypsin
although
oxyanion
stabil
effect
aldehyd
hemiacet
oxyanion
glyoxal
hemiket
oxyanion
tabl
pka
imidazolium
ion
rais
hemiacet
format
tabl
rais
n
hemiket
format
glyoxal
complex
inhibitor
n
peptidyl
trifluoromethyl
keton
peptidyl
boron
acid
inhibitor
form
neg
charg
tetrahedr
adduct
chymotrypsin
show
oxyanion
format
minor
role
rais
pka
imidazolium
ion
aldehyd
inhibitor
complex
therefor
replac
aldehyd
hydrogen
aldehyd
group
trifluoromethylen
group
major
factor
strengthen
hydrogen
bond
rais
pk
imidazolium
ion
ensur
tetrahedr
intermedi
format
stereospecif
similar
effect
expect
catalysi
substrat
therefor
tetrahedr
adduct
format
increas
strength
hydrogen
bond
aspart
histidin
residu
rais
pk
imidazolium
ion
valu
n
leav
group
peptid
nitrogen
present
inhibitor
carbon
atom
present
equival
posit
suggest
inhibitor
aldehyd
hydrogen
atom
larg
enough
compress
hydrogen
bond
andor
screen
solvent
histidin
pk
rais
valu
n
likewis
aldehyd
proton
must
replac
larger
group
ensur
format
tetrahedr
speci
stereospecif
catalyt
serin
group
expect
pk
imidazolium
ion
act
effect
base
catalyst
pka
rais
valu
free
enzym
valu
similar
activ
site
serin
hydroxyl
group
substrat
ppm
ppm
b
pk
ppm
ppm
c
pk
ppm
ppm
pk
ppm
ppm
tabl
titrat
constant
ph
depend
chang
chemic
shift
n
proton
complex
bind
aldehyd
inhibitor
small
effect
pk
activ
site
histidin
tetrahedr
adduct
format
fact
effect
molar
hydroxyl
group
catalyt
serin
group
lower
aldehyd
inhibitor
compar
equival
glyoxal
inhibitor
tabl
show
larg
increas
pk
requir
increas
reactiv
serin
hydroxyl
group
format
tetrahedr
hemiacet
suggest
expect
increas
effect
molar
activ
site
serin
hydroxyl
requir
tetrahedr
intermedi
format
catalysi
sole
attribut
larg
increas
pk
therefor
propos
primari
reason
increas
effect
molar
catalyt
hydroxyl
bind
substrat
entrop
advantag
achiev
optim
align
catalyt
serin
hydroxi
group
carbonyl
carbon
peptid
hydrolys
conclud
moieti
larger
aldehyd
proton
must
present
pk
activ
site
histidin
rais
valu
stereospecif
format
tetrahedr
adduct
aldehyd
inhibitor
stabil
hemiacet
oxyanion
pk
reduc
pk
unit
pk
activ
site
histidin
pka
unit
therefor
conclud
larg
increas
pk
activ
site
histidin
requir
oxyanion
stabil
activ
site
serin
hydroxyl
group
effect
molar
activ
site
serin
hydroxyl
group
expect
argu
larg
increas
pka
activ
site
histidin
ie
pka
n
observ
bind
glyoxal
inhibitor
requir
increas
reactiv
serin
hydroxyl
group
gener
acid
catalysi
aldehyd
inhibitor
small
increas
pka
activ
site
histidin
pka
howev
effect
molar
serin
hydroxyl
group
aldehyd
inhibitor
fold
smaller
observ
correspond
glyoxal
inhibitor
tabl
clearli
demonstr
small
part
high
reactiv
serin
hydroxyl
group
attribut
gener
base
catalysi
catalyt
histidin
residu
chymotrypsin
